Drug user

Results: 1369



#Item
321Accounts receivable / Food and Drug Administration / Pharmaceuticals policy / Prescription Drug User Fee Act

CARRYOVER BALANCES Under PDUFA, fees collected, appropriated, and not obligated at the end of a fiscal year remain available to FDA in future fiscal years. They are referred to as carryover balances. The operations in FY

Add to Reading List

Source URL: www.fda.gov

Language: English
322Pharmacology / Clinical research / Prescription Drug User Fee Act / Pharmaceutical industry / Drug safety / New Drug Application / Drug development / Food and Drug Administration / Pharmaceutical sciences / Pharmaceuticals policy

FY 2013 PDUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
323Food and Drug Administration / Clinical pharmacology / Pharmacology / Therapeutics / United States Public Health Service / General Services Administration / Prescription Drug User Fee Act / United States Department of Homeland Security / Fee / Pharmaceutical sciences / Clinical research / Government

Infrastructure GSA Rent, Other Rent and White Oak Consolidation

Add to Reading List

Source URL: www.fda.gov

Language: English
324Pharmaceuticals policy / Pharmacology / Prescription Drug User Fee Act / Clinical research / Pharmaceutical industry / New Drug Application / Clinical trial / Food and Drug Administration Modernization Act / Food and Drug Administration / Pharmaceutical sciences / Health

Microsoft Word - PDUFA FY 2011 clean[removed]doc

Add to Reading List

Source URL: www.fda.gov

Language: English
325Health / Medicine / Pharmacology / Prescription Drug User Fee Act / Food law / Federal Food /  Drug /  and Cosmetic Act / Pharmaceutical industry / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

FY 2011 PDUFA FINANCIAL REPORT REQUIRED BY THE PRESCRIPTION DRUG USER FEE ACT AS AMENDED

Add to Reading List

Source URL: www.fda.gov

Language: English
326Health / Medicine / Pharmacology / Prescription Drug User Fee Act / Food law / Federal Food /  Drug /  and Cosmetic Act / Pharmaceutical industry / Fee / Food and Drug Administration / Pharmaceuticals policy / Pharmaceutical sciences

FY 2013 PDUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
327Pharmaceutical sciences / Health / Fee / Food and Drug Administration / Pharmaceuticals policy / Prescription Drug User Fee Act

FY 2013 PDUFA Financial Report

Add to Reading List

Source URL: www.fda.gov

Language: English
328Drug culture / Stimulants / Cocaine / Crack cocaine / Substance abuse / Illegal drug trade / Drug user / Substance use disorder / Arguments for and against drug prohibition / Medicine / Pharmacology / Chemistry

Framing the Policy & Practice Debate On Substance Exposed Newborns Substance Exposed Newborns:

Add to Reading List

Source URL: aia.berkeley.edu

Language: English - Date: 2008-12-06 04:46:48
329Health / Pharmacology / Pharmaceuticals policy / Drug Enforcement Administration / Pharmaceutical industry / Controlled Substances Act / Prescription Drug User Fee Act / Clinical trial / Removal of cannabis from Schedule I of the Controlled Substances Act / Food and Drug Administration / Pharmaceutical sciences / Research

Opening Statement of the Honorable Joseph R. Pitts Subcommittee on Health Hearing on “Improving Predictability and Transparency in DEA and FDA Regulation” April 7, 2014 (As Prepared for Delivery) Today’s legislativ

Add to Reading List

Source URL: energycommerce.house.gov

Language: English - Date: 2014-04-07 10:47:03
330Pharmaceutical sciences / Prescription Drug User Fee Act / Clinical research / Abbreviated New Drug Application / Regulatory requirement / Pharmaceuticals policy / Food and Drug Administration / Health

MANAGEMENT CHALLENGES FOR FY 2013 Since the implementation of PDUFA I, FDA has used PDUFA resources to significantly reduce the time it takes to evaluate new drugs and biologics without compromising FDA’s rigorous stan

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE